February 16, 2017
Vienna and San Diego-based digital health company mySugr has come out of the International Conference on Advanced Technologies and Treatments for Diabetes with two big pieces of news: study results that show impressive efficacy of the app in high-risk populations and an expansion of its partnership with Roche.
The study looked at 440 mySugr users randomly selected from a group of high-risk (HbA1C...
January 30, 2017
Milpitas, California-based Bigfoot Biomedical, a diabetes management company working on their first product, announced an investment from the Juvenile Diabetes Research Foundation (JDRF)’s newly launched venture fund, T1D, focused on early stage companies working on type 1 diabetes. The terms of the investment were not disclosed, but Bigfoot previously raised $35.5 million.
The funding will be...
January 9, 2017
Mountain View, California-based Glooko is collaborating with Danish pharmaceutical company Novo Nordisk to develop a digital diabetes management platform.
The non-exclusive partnership, developed and branded by both companies, will combine Glooko’s digital capabilities and Novo Nordisk’s deep knowledge of diabetes. Glooko offers a mobile, cloud-based platform for people with diabetes to track and...
December 19, 2016
The FDA has cleared the wireless integration of one of Johnson and Johnson subsidiary LifeScan’s blood glucose monitoring systems and WellDoc’s digital diabetes management platform for people with type 2 diabetes.
The two companies originally teamed up in March of this year. The integrated system consists of OneTouch Verio Flex, LifeScan’s Bluetooth smart blood glucose monitoring system and...
December 7, 2016
Medical device maker Medtronic has teamed up with Fitbit to integrate physical activity data with blood glucose levels into one streamlined application.
People living with type 2 diabetes who use Medtronic's iPro2 continuous glucose monitoring system and its companion app, iPro2 myLog, will now be able to have their Fitbit data automatically synced to the app, enabling them to easily see the...
December 7, 2016
BioTelemetry, formerly known as CardioNet, has acquired TelCare, a diabetes management technology company with the distinction of having had the first FDA-cleared, cellular-connected glucometer. BioTelemetry paid $7 million in cash with the potential for additional performance-based earn-outs of up to $5 million, also in cash. Both BioTelemetry and TelCare are veterans of the early days of the...
December 2, 2016
Germantown, Maryland-based Senseonics, which is working on a long-term implantable continuous glucose monitor called Eversense, has expanded its exclusive distribution agreement with Roche.
Now, Roche will have exclusive rights to promote, market and sell the Eversense product line to diabetes clinics and patients in in most of Europe (excluding Scandinavia and Finland), the Middle East (except...
November 11, 2016
Israel-based DarioHealth, which makes a smartphone-connected blood glucose monitor, has made significant headway in the US, Australian and Canadian markets, seling 5,500 devices in the US this quarter and 8,500 worldwide.
The company launched in the US in March, and quickly built up a customer base with more than 100 percent increase in growth by the second quarter. Coasting on that wave of new...
October 19, 2016
Milpitas, California-based diabetes management company Bigfoot Biomedical has raised $35.5 million in Series A funding in a round with participation from Cormorant Asset Management, Senvest Capital and Visionnaire Ventures. The funding will be used to further develop the company’s connected, automated insulin delivery service.
Bigfoot bills itself as “drawing a circle around everything that it...
October 7, 2016
As we take a look at the devices that received FDA clearance in 2016's third quarter, we're also considering that the last few months have been a time of change at the Food and Drug Administration, as regulators are beginning to make updates in their system to accomodate all the digital health tools we're seeing.
In June, the FDA offered up a draft guidance document designed to help medical...